Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 12, 2012
Antibody response to Merkel cell polyomavirus associated with incident lymphoma in the Epilymph case-control study in SpainClaudia Robles, Andre Poloczek, Delphine Casabonne, et al.
Cancer Immunology, Immunotherapy : CII|July 24, 2010
Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particlesSharmila Pejawar-Gaddy, Yogendra Rajawat, Zoe Hilioti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 2005
Antibody responses to simian virus 40 T antigen: a case-control study of non-Hodgkin lymphomaEric A Engels, Jinbo Chen, Patricia Hartge, et al.
Microbes and Infection|November 13, 2012
The Toxoplasma MAG1 peptides induce sex-based humoral immune response in mice and distinguish active from chronic human infectionJianchun Xiao, Raphael P Viscidi, Geetha Kannan, et al.
Vaccine|January 3, 2012
Development of a DNA vaccine targeting Merkel cell polyomavirusQi Zeng, Bianca P Gomez, Raphael P Viscidi, et al.
Plos Pathogens|April 19, 2012
Neutralization serotyping of BK polyomavirus infection in kidney transplant recipientsDiana V Pastrana, Daniel C Brennan, Nicolas Cuburu, et al.
The Journal of Infectious Diseases|December 18, 2012
A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United StatesPatti E Gravitt, Anne F Rositch, Michelle I Silver, et al.
The Lancet. Infectious Diseases|May 27, 2009
Clinician's guide to human papillomavirus immunology: knowns and unknownsMark H Einstein, John T Schiller, Raphael P Viscidi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2021
Serological Responses to Toxoplasma gondii and Matrix Antigen 1 Predict the Risk of Subsequent Toxoplasmic Encephalitis in People Living With Human Immunodeficiency Virus (HIV)Jianchun Xiao, Fiona Bhondoekhan, Eric C Seaberg, et al.
Pageof 10